Skip to main navigation Skip to search Skip to main content

Immunohistochemical pattern of p53 is a measure of TP53 mutation burden and adverse clinical outcome in myelodysplastic syndromes and secondary acute myeloid leukemia

  • Kathy L. McGraw
  • , Johnny Nguyen
  • , Rami S. Komrokji
  • , David Sallman
  • , Najla H. Al Ali
  • , Eric Padron
  • , Jeffrey E. Lancet
  • , Lynn C. Moscinski
  • , Alan F. List
  • , Ling Zhang
  • University of South Florida

Research output: Contribution to journal › Letter › peer-review

57 Scopus citations
Original languageEnglish
Pages (from-to)e320-e323
JournalHaematologica
Volume101
Issue number8
DOIs
StatePublished - 31 Jul 2016
Externally publishedYes

Keywords

  • IHC
  • Myelodysplastic syndromes
  • TP53

Cite this